CLIA GAD65

High-performance autoantibody diagnostics for diabetes
Fast. Automated. Precise – for reliable differentiation of autoimmune forms of diabetes on the KleeYa® platform

The CLIA GAD65 test is an automated quantitative chemiluminescence immunoassay for the detection of IgG autoantibodies against glutamate decarboxylase 65 in human serum and plasma. The test supports the diagnostic investigation and classification of autoimmune diabetes.

GAD65 autoantibodies are among the most important markers of autoimmune damage to the insulin-producing beta cells of the pancreas. The progressive loss of these cells leads to decreasing endogenous insulin production and may ultimately result in manifest type 1 diabetes.

As GAD65 autoantibodies are often detectable before the onset of clinical symptoms, they support the early detection and diagnostic classification of autoimmune diabetes. Particularly in adult patients, in atypical disease courses or when classification is unclear, their detection helps distinguish type 2 diabetes and identify latent autoimmune diabetes in adults (LADA).

While GAD65 and IA-2 autoantibodies indicate autoimmune damage to beta cells, C-peptide and insulin allow assessment of remaining endogenous insulin production. Their combined determination therefore supports both diagnostic classification of the form of diabetes and assessment of beta-cell function.

What We Offer You

Reagents for 100 determinatons
Article no.: 71125 Request
2 x 20 determinations
Article no.: 71378 Request

Why CLIA GAD65?

  • Quantitative detection of IgG autoantibodies against GAD65
  • No use of radioactive materials as required for RIA methods
  • Helps detect autoimmune diabetes at an early stage, even in patients with unusual symptoms or an unclear diagnosis
  • Adds clinical value when standard classification is insufficient and contributes to a better understanding of disease etiology
  • Combination of GAD65 and IA-2 with insulin and C-peptide – rarely available on CLIA platforms

Technische Daten

Test kit stability30 days on board / stability during use until the expiration date when stored at 2–8 °C
Sample matrixSerum, Plasma
Sample volume60 μl per determination
Time to first result50 min
Measuring range0–500 U/ml
Kit contentsReagent cartridge with assay-specific reagents, magnetic beads and calibrators
Supplementary productsAnchor® Tips, stackable cuvettes, KleeYa® Trigger Pack, KleeYa® Wash Buffer

Flexible. Compatible. Efficient.

Modern CLIA technology, random-access automation, up to 16 assay parameters in parallel, high sample throughput – up to 120 analyses per hour, LIS/middleware connectivity

Simple. Fast. Reliable.

Standardized processing, ready-to-use test cartridges, short assay times of 30 to 50 min, easy integration into laboratory routine, IVDR-compliant and CE-marked

Ideal for…

Laboratories seeking to implement innovative random-access technology for both high-throughput and niche parameters